On Tuesday October 6th 2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”.
Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands, discussed the role of the biomarkers in the follow-up of NMIBC, and then zoomed in on Bladder EpiCheck, which is used as standard of care in his hospital.
Three urologists from Spain (Prof. Dr. Joaquín Carballido, Dr. Marc Serrallach and Dr. Félix Guerrero) presented how the Bladder EpiCheck test is used in their clinical public and private practice, while Dr. David Parada, pathologist, discussed Bladder EpiCheck from the pathologist’s point of view. These presentations were given in Spanish and are subtitled into English.
At the end of the session, some questions from the audience were discussed.